Synergistic effect of diosmin and interferon-α on metastatic pulmonary melanoma

Cancer Biotherapy and Radiopharmaceuticals

Volumn 24, Issue 3, 2009, Pages 347-352

  Álvarez, Nuria ^a   Vicente, Vicente ^a   Martínez, Cristina ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b INSTITUTO MURCIANO DE INVESTIGACIÓN Y DESARROLLO AGRARIO Y ALIMENTARIO IMIDA   (Spain)

Author keywords

Diosmin; Flavonoid; Interferon alpha; Lung; Melanoma; Metastasis

Indexed keywords

ALPHA INTERFERON; DIOSMIN; RECOMBINANT ALPHA2B INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG POTENTIATION; FEMALE; IMAGE ANALYSIS; INOCULATION; LUNG METASTASIS; MELANOMA; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL PROLIFERATION; DIOSMIN; DRUG SYNERGISM; FEMALE; INTERFERON ALFA-2B; INTERFERON-ALPHA; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS;

EID: 67650787380     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2008.0565     Document Type: Article

References (41)

1. Horn-Ross PL. Melanoma in the Greater San Francisco Bay Area 1988-2000. Northern California Cancer Center (serial online). Online document at: www.nccc.org/atf/cf/% 7BC580CD0D-E445-46F8-97CF-443A3570F%7D/MELANOMA %GREAT%20SF%BAY.pdf Accessed May 12, 2009.
2. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004;40:2355.
3. Leiter U, Meier F, Schittek B, et al. The natural course of cutaneous melanoma. J Surg Oncol 2004;86:172.
4. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635.
5. Lens MB, Dawes M. Interferon alfa therapy for malignant melanoma: A systematic review of randomized, controlled trials. J Clin Oncol 2002;20:1818.
6. Belardelli F, Ferrantini M, Proietti E, et al. Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev 2002;13:119.
7. Yano H, Yanai Y, Momosaki S, et al. Growth-inhibitory effects of interferon-alpha subtypes vary according to human liver cancer cell lines. J Gastroenterol Hepatol 2006;21:1720.
8. Caraglia M, Marra M, Pelaia G, et al. Alpha-interferon and its effects on signal transduction pathways. J Cell Physiol 2005;202:323.
9. Avnet S, Cenni E, Perut F, et al. Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis. Int J Oncol 2007;30:469.
10. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002;96(2-3):67.
11. Ramelet AA. Clinical benefits of Daflon 500mg in the most severe stages of chronic venous insufficiency. Angiology 2001;52 (Suppl 1):S49.
12. Nicolaides AN. From symptoms to leg edema: Efficacy of Daflon 500 mg. Angiology 2003;54 (Suppl 1):S33.
13. Sroka Z, Fecka I, Cisowski W. Antiradical and anti-H2O2 properties of polyphenolic compounds from an aqueous peppermint extract. Z Naturforsch [C] 2005;60(11-12):826.
14. Bear WL, Teel RW. Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity. Anticancer Res 2000;20:3609.
15. Manthey JA. Biological properties of flavonoids pertaining to inflammation. Microcirculation 2000;7(6 Pt 2):S29.
16. Tanaka T, Kohno H, Mori H. Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds. Asian Pac J Cancer Prev 2001;2(3):165.
17. Tanaka T, Makita H, Kawabata K, et al. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin, and hesperidin. Carcinogenesis 1997;18:957.
18. Yang M, Tanaka T, Hirose Y, et al. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int J Cancer 1997;73:719.
19. Martínez Conesa C, Vicente Ortega V, Yáñez Gascón MJ, et al. Treatment of metastatic melanoma B16F10 by the fla-vonoids tangeretin, rutin, and diosmin. J Agric Food Chem 2005;53:6791.
20. Martínez Conesa C, Vicente Ortega V, Yáñez Gascón MJ, et al. Experimental model for treating pulmonary metastatic melanoma using grape-seed extract, red wine, and ethanol. Clin Transl Oncol 2005;7:115.
21. Lentini A, Autuori F, Mattioli P, et al. Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis. Eur J Cancer 2000;36: 1572.
22. Martínez C, Vicente V, Yáñez J, et al. The effect of the flavonoid diosmin, grape seed extract, and red wine on the pulmonary metastatic B16F10 melanoma. Histol Histopathol 2005;20:1121.
23. Martínez C, Vicente V, Yañ ez J, et al. Experimental model of pulmonary metastasis treatment with IFN-α. Cancer Lett 2005;225:75.
24. Lentini A, Kleinman HK, Mattioli P, et al. Inhibition of melanoma pulmonary metastasis by methylxanthines due to decreased invasion and proliferation. Melanoma Res 1998;8:131.
25. Wu WJ, Pruett SB. Ethanol decreases host resistance to pulmonary metastases in a mouse model: role of natural killer cells and the ethanol-induced stress response. Int J Cancer 1999;82:886.
26. Blank SE, Meadows GG. Ethanol modulates metastatic potential of B16BL6 melanoma and host responses. Alcohol Clin Exp Res 1996;20:624.
27. Wen Y, Yan DH, Wang B, et al. p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models. Cancer Res 2001;61:7142.
28. Slaton JW, Karashima T, Perrotte P, et al. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Clin Cancer Res 2001;7:2840.
29. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005;9:267.
30. Gutman H, Schachter J, Stopel E, et al. Impaired platelet aggregation in melanoma patients treated with interferon-alpha-2b adjuvant therapy. Cancer 2002;94:780.
31. Palumbo JS, Talmage KE, Massari JV, et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 2005;105:178.
32. Im JH, Fu W, Wang H, et al. Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 2004;64:8613.
33. Hakansson A, Gustafsson B, Krysander L, et al. Effect of IFN-alpha on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma. J Interf Cytok Res 1998;18:33.
34. Smith PC. Daflon 500mg and venous leg ulcer: New results from a meta-analysis. Angiology 2005;56 (Suppl 1):S33.
35. Bostrom PJ, Uotila P, Rajala P, et al. Interferon-alpha inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in vitro. Urol Res 2001;29:20.
36. Blank VC, Poli C, Marder M, et al. Antiproliferative activity of various flavonoids and related compounds: Additive effect of interferon-alpha2b. Bioorg Med Chem Lett 2004;14:133.
37. Yu YS, Tang ZH, Han JC, et al. Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 alpha DCs induced in vivo by IFN-alpha in patients with chronic hepatitis B. World J Gastroenterol 2006;12:1447.
38. Comalada M, Ballester I, Bailon E, et al. Inhibition of proinflammatory markersin primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: Analysis of the structure-activity relationship. Biochem Pharmacol 2006; 72:1010.
39. Tedeschi E, Suzuki H, Menegazzi M. Anti-inflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition. Ann N Y Acad Sci 2002;973:435.
40. Matsuda T, Ferreri K, Todorov I, et al. Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: Implication of c-Jun NH2-terminal kinase and janus kinase/ signal transducer and activator of transcription pathways. Endocrinology 2005;146:175.
41. Kim AL, Zhu Y, Zhu H, et al. Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. Exp Dermatol 2006;15:538.